Glenn Barba, CMS Energy (CMS)’s insider Unloaded 10,000 Shares; Last Week Valeant Pharmaceuticals International, Inc. (VRX) Coverage

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) Logo

Among 28 analysts covering Valeant Pharmaceuticals Intl (NYSE:VRX), 7 have Buy rating, 5 Sell and 16 Hold. Therefore 25% are positive. Valeant Pharmaceuticals Intl had 163 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was maintained by Jefferies on Monday, November 2 with “Buy”. Rodman & Renshaw maintained it with “Buy” rating and $105 target in Monday, April 11 report. Piper Jaffray maintained Valeant Pharmaceuticals International, Inc. (NYSE:VRX) rating on Friday, September 15. Piper Jaffray has “Sell” rating and $14.0 target. Mizuho upgraded the shares of VRX in report on Tuesday, October 27 to “Buy” rating. Deutsche Bank upgraded the shares of VRX in report on Monday, March 5 to “Buy” rating. Mizuho initiated Valeant Pharmaceuticals International, Inc. (NYSE:VRX) on Friday, October 9 with “Neutral” rating. As per Wednesday, September 30, the company rating was maintained by Bank of America. The rating was maintained by BMO Capital Markets with “Market Perform” on Thursday, May 11. As per Thursday, November 9, the company rating was maintained by BTIG Research. The firm has “Overweight” rating given on Friday, June 16 by Cantor Fitzgerald. See Valeant Pharmaceuticals International, Inc. (NYSE:VRX) latest ratings:

02/05/2018 Broker: RBC Capital Markets Rating: Hold New Target: $18.0000 Maintain
06/04/2018 Broker: Mizuho Rating: Hold Upgrade
06/04/2018 Broker: Inc. Rating: Mizuho New Target: $11
15/03/2018 Broker: H.C. Wainwright Rating: Hold New Target: $16.0 Maintain
08/03/2018 Broker: Susquehanna Rating: Hold New Target: $17.0 Maintain
05/03/2018 Broker: Deutsche Bank Rating: Buy Upgrade
05/03/2018 Broker: Inc. Rating: Deutsche Bank New Target: $18
01/03/2018 Broker: Piper Jaffray Rating: Sell New Target: $10.0 Maintain
28/02/2018 Broker: CFRA Rating: Hold Downgrade
28/02/2018 Broker: Cantor Fitzgerald Rating: Buy New Target: $25.0 Maintain

Since March 8, 2018, it had 3 insider buys, and 0 sales for $876,370 activity. PAPA JOSEPH C bought $481,500 worth of stock or 30,000 shares. DE SCHUTTER RICHARD U also bought $153,400 worth of Valeant Pharmaceuticals International, Inc. (NYSE:VRX) shares. Shares for $241,470 were bought by Herendeen Paul.

Investors sentiment decreased to 0.97 in 2017 Q4. Its down 0.02, from 0.99 in 2017Q3. It fall, as 51 investors sold Valeant Pharmaceuticals International, Inc. shares while 74 reduced holdings. 54 funds opened positions while 67 raised stakes. 169.66 million shares or 0.12% less from 169.87 million shares in 2017Q3 were reported. Envestnet Asset reported 0% in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Creative Planning owns 353,656 shares for 0.03% of their portfolio. Moreover, Intact Inv Mgmt has 0.13% invested in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Apg Asset Management Nv accumulated 68,154 shares or 0% of the stock. Pictet Asset Mngmt has invested 0.01% of its portfolio in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Clinton has invested 0.18% in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Wells Fargo And Com Mn reported 271,299 shares. Jefferies Gp Ltd Liability Corporation reported 0.07% stake. Northern has invested 0% in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Janney Montgomery Scott Lc reported 12,550 shares stake. Ls Inv Advsr Limited Company has 140 shares for 0% of their portfolio. Gulf Natl Bank (Uk) Limited invested in 98,923 shares. First Allied Advisory Svcs accumulated 0.01% or 11,301 shares. Manufacturers Life Ins The has invested 0.03% in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). State Of Tennessee Treasury Department reported 257,625 shares stake.

More notable recent Valeant Pharmaceuticals International, Inc. (NYSE:VRX) news were published by: Benzinga.com which released: “Steve Sosnick’s Valeant Options Trade” on May 04, 2018, also Seekingalpha.com with their article: “Valeant: An Edge Into Earnings” published on April 24, 2018, Seekingalpha.com published: “Multiply Your Money With Valeant” on April 10, 2018. More interesting news about Valeant Pharmaceuticals International, Inc. (NYSE:VRX) were released by: Streetinsider.com and their article: “Valeant Pharma’s (VRX) Bausch + Lomb Announces FDA Approval for ULTRA Extended Wear Indication” published on May 02, 2018 as well as Prnewswire.com‘s news article titled: “Pre-Market Technical Scan on Drug Delivery Equities — Adamis Pharma, Alkermes, PetMed Express, and Valeant …” with publication date: May 04, 2018.

The stock decreased 1.39% or $0.25 during the last trading session, reaching $17.76. About 6.54 million shares traded. Valeant Pharmaceuticals International, Inc. (NYSE:VRX) has risen 42.00% since May 4, 2017 and is uptrending. It has outperformed by 30.45% the S&P500.

Valeant Pharmaceuticals International, Inc. operates as a pharmaceutical and medical device firm worldwide. The company has market cap of $6.20 billion. It operates in three divisions: Bausch + Lomb/International, Branded Rx, and U.S. It has a 2.6 P/E ratio. Diversified Products.

Since February 20, 2018, it had 0 insider buys, and 1 sale for $360,629 activity. On Tuesday, February 20 the insider Reynolds Catherine M sold $360,629.

Among 17 analysts covering CMS Energy Corporation (NYSE:CMS), 7 have Buy rating, 0 Sell and 10 Hold. Therefore 41% are positive. CMS Energy Corporation has $55.0 highest and $32 lowest target. $46.31’s average target is -0.34% below currents $46.47 stock price. CMS Energy Corporation had 51 analyst reports since August 31, 2015 according to SRatingsIntel. The stock of CMS Energy Corporation (NYSE:CMS) has “Neutral” rating given on Monday, October 26 by UBS. The firm has “Sector Perform” rating given on Friday, July 15 by Scotia Capital. RBC Capital Markets maintained the stock with “Hold” rating in Sunday, September 10 report. RBC Capital Markets maintained it with “Hold” rating and $46.0 target in Sunday, October 15 report. The firm has “Neutral” rating by Credit Suisse given on Wednesday, January 25. The rating was maintained by Morgan Stanley with “Equal-Weight” on Monday, April 16. The stock of CMS Energy Corporation (NYSE:CMS) has “Equal-Weight” rating given on Monday, November 13 by Morgan Stanley. SunTrust maintained the stock with “Neutral” rating in Monday, September 26 report. On Monday, March 19 the stock rating was maintained by SunTrust with “Hold”. SunTrust maintained CMS Energy Corporation (NYSE:CMS) rating on Monday, November 20. SunTrust has “Hold” rating and $50.0 target.

The stock decreased 0.07% or $0.03 during the last trading session, reaching $46.47. About 2.33 million shares traded. CMS Energy Corporation (NYSE:CMS) has declined 0.78% since May 4, 2017 and is downtrending. It has underperformed by 12.33% the S&P500.

CMS Energy Corporation operates as an energy firm primarily in Michigan. The company has market cap of $13.13 billion. It operates through three divisions: Electric Utility, Gas Utility, and Enterprises. It has a 28.34 P/E ratio. The Electric Utility segment engages in the generation, purchase, transmission, distribution, and sale of electricity.

Glenn Barba, VP – Controller – CAO of Cms Energy Corp, in an insider legal trading deal sold 10,000 shares whose sum is estimated to be $468,500 at average stock price of $46.9. The regulatory filing shows that Glenn Barba now has around 0.01% of the Michigan-based company’s total market cap The sale was revealed in a SEC document on 03/05/2018.

Investors sentiment increased to 1.4 in 2017 Q4. Its up 0.43, from 0.97 in 2017Q3. It increased, as 26 investors sold CMS Energy Corporation shares while 128 reduced holdings. 52 funds opened positions while 164 raised stakes. 235.44 million shares or 0.35% more from 234.63 million shares in 2017Q3 were reported. Mutual Of America Mgmt Limited Liability Corporation has invested 0.03% in CMS Energy Corporation (NYSE:CMS). Quantitative Systematic Strategies Limited Liability Com, Connecticut-based fund reported 24,429 shares. Blue Chip Prtnrs has 3,316 shares for 0.05% of their portfolio. Amer Ins Tx reported 0.34% of its portfolio in CMS Energy Corporation (NYSE:CMS). 596,705 are owned by Rhumbline Advisers. Pictet North America Advsrs Sa, a Switzerland-based fund reported 38,564 shares. Raymond James And Assocs holds 88,930 shares. Teachers Ins & Annuity Association Of America holds 0.04% or 15,132 shares. 25,225 are owned by Commonwealth Of Pennsylvania School Empls Retrmt Systems. 5,211 are owned by Bokf Na. Fort Washington Invest Advsr Oh holds 0.01% or 25,400 shares in its portfolio. Strs Ohio holds 0.01% of its portfolio in CMS Energy Corporation (NYSE:CMS) for 56,923 shares. Boothbay Fund Mgmt Limited Liability Corp, New York-based fund reported 5,787 shares. Voya Ltd reported 0.01% in CMS Energy Corporation (NYSE:CMS). Deutsche Natl Bank Ag reported 838,800 shares.

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) Institutional Positions Chart